Vaccination

FDA experts weigh authorizing Novavax COVID-19 vaccine in US

A panel of experts convened by the US drug regulator was meeting Tuesday to consider authorizing the Novavax COVID-19 shot, a late runner in the fight against the virus that could nonetheless play a role in overcoming vaccine ...

Medical economics

Start talking about mRNA vaccine access now, say experts

While researchers are still in the early stages of development for new mRNA vaccines, global health leaders focused on the world's most neglected infectious diseases say that conversations about access should begin now.

Vaccination

The world of vaccines, before and after COVID

The COVID-19 pandemic has forever changed the world's relationship to vaccines, spurring unprecedented production and innovation even while poorer nations were left behind.

Medical research

Are we any closer to an HIV vaccine?

While scientists have made unprecedented progress in preventing COVID-19 in the past two years, they have also moved closer to finding a vaccine to protect against the human immunodeficiency virus (HIV), which has been infecting ...

page 6 from 30